Skip to main navigation Skip to search Skip to main content

Engineering high-affinity ociperlimab mutants through structure-based antibody optimization

  • Beijing Institute of Technology

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

TIGIT acts as a pivotal inhibitory receptor mediating T-cell dysfunction and immune evasion. Using structure-guided saturation mutagenesis of Ociperlimab, we identified several variants, most notably the pentamutant Ociperlimab MP5 and the single-point mutant Ociperlimab SP16, which exhibited significantly improved binding free energies. Beyond affinity enhancement, these mutants demonstrated optimized developability profiles, including reduced aggregation propensity and a marked increase in heavy-chain humanization. Mechanistic analyses revealed that these optimized variants strengthen key interface interactions, enhancing T-cell activation and effector functions. In vitro and in vivo studies demonstrated improved immune responses, including increased T-cell proliferation and functional cytokine secretion. These results provide a mechanistic framework for rational antibody optimization, offering a pathway to more effective TIGIT-targeted immunotherapies.

Original languageEnglish
Title of host publicationInternational Conference on Imaging Processing for Medical-Oriented Recognition, IPOR 2025
EditorsPor Lip Yee, Thippa Reddy Gadekallu
PublisherSPIE
ISBN (Electronic)9798902323747
DOIs
Publication statusPublished - 19 Mar 2026
Externally publishedYes
Event2025 International Conference on Imaging Processing for Medical-Oriented Recognition, IPOR 2025 - Kuala Lumpur, Malaysia
Duration: 27 Nov 202529 Nov 2025

Publication series

NameProceedings of SPIE - The International Society for Optical Engineering
Volume14160
ISSN (Print)0277-786X
ISSN (Electronic)1996-756X

Conference

Conference2025 International Conference on Imaging Processing for Medical-Oriented Recognition, IPOR 2025
Country/TerritoryMalaysia
CityKuala Lumpur
Period27/11/2529/11/25

Keywords

  • Immune checkpoint inhibitors
  • Mechanistic study
  • Ociperlimab mutant
  • T cell function
  • TIGIT

Fingerprint

Dive into the research topics of 'Engineering high-affinity ociperlimab mutants through structure-based antibody optimization'. Together they form a unique fingerprint.

Cite this